Skip to main content
VCbacked
Log inGet Started

Virion Therapeutics

Newark, United States

Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.

$95K raised
Oct 2024
Undisclosed
BiotechnologyHealth CareTherapeutics

Top Investors

Keiretsu CapitalLife Science AngelsMid Atlantic Bio AngelsKeiretsu ForumPuget Sound Venture Club

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Virion Therapeutics

How much funding has Virion Therapeutics raised?
Virion Therapeutics has raised $95K in total funding. The most recent round was Undisclosed. The last funding was announced in October 2024.
Who are Virion Therapeutics's investors?
Virion Therapeutics's investors include Keiretsu Capital, Life Science Angels, Mid Atlantic Bio Angels, Keiretsu Forum, Puget Sound Venture Club.
Where is Virion Therapeutics headquartered?
Virion Therapeutics is headquartered in Newark, United States.
What does Virion Therapeutics do?
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
What stage is Virion Therapeutics at?
Virion Therapeutics is at the Undisclosed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Virion Therapeutics — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/virion-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Virion Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/virion-therapeutics
Wikipedia (cite web)
{{cite web |title=Virion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/virion-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K